Hester Biosciences Ltd Share Price (HESTERBIO)
Check the latest share price of Hester Biosciences Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
₹1798
▲0.63%
as on 04:01PM, 04 Jun 2025
NSE
Hester Biosciences Ltd Stock Performance
Get live Hester Biosciences Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹1,762.1Day's Price Range₹1,80852 Week's Low
52 Week's High
₹1,242.9552-Week Price Range₹3,379
| Returns % | |
| 1 Month Return | -1.01 % |
| 3 Month Return | + 25.2 % |
| 1 Year Return | + 7.51 % |
| 3 Year Return | -23.1 % |
| 5 Year Return | + 39.46 % |
| Market Stats | |
| Previous Close | ₹1,786.80 |
| Open | ₹1,808.00 |
| Volume | 2,290.00 |
| Upper Circuit | ₹2,144.10 |
| Lower Circuit | ₹1,429.50 |
Hester Biosciences Ltd Fundamentals & Key Indicators
Check Hester Biosciences Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,520.01 Cr
Return on Equity (ROE)
8.98
PE Ratio (TTM)
52.72
Return on capital employed (ROCE)
8.51
Industry PE ratio
55.92
Beta (LTM)
0.83
P/B Ratio
3.78
Dividend Yield
0.43
PEG Ratio
5.86
Quarterly Earnings Growth YOY
-75.94
EPS (TTM)
24.88
Sector
Pharmaceuticals
Book Value
343
Technical Analysis
Bullish
View Technical Analysis
How to invest in Hester Biosciences Ltd?
Investing in Hester Biosciences Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Hester Biosciences Ltd or HESTERBIO on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Hester Biosciences Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Hester Biosciences Ltd with just a few clicks!
Hester Biosciences Ltd Stock's Interest Amongst Investors
Hester Biosciences Ltd Valuation
Track how Hester Biosciences Ltd P/E has moved over time to understand its valuation trends.
Hester Biosciences Ltd in the last 5 years
Lowest (19.52x)
March 23, 2020
Today (52.72x)
June 3, 2025
Industry (55.92x)
June 3, 2025
Highest (124.52x)
July 26, 2024
Today’s Price to Earnings Ratio: 52.72x
Hester Biosciences Ltd Share Price Target
Get share price movements and forecasts by analysts on Hester Biosciences Ltd.
Excluding Excise Duty and Other Income, represents Net Revenue
Hester Biosciences Ltd revenue growth forecast
Expected growth rate Q1, FY2023:0.94%
Forecast
Actual
Including amortisation and stock based compensations
Hester Biosciences Ltd EPS growth forecast
EPS estimate Q1, FY2023:13.74%
Forecast
Actual
Source: S&P Global Market Intelligence
Hester Biosciences Ltd Financial Results
Get the annual and quarterly financial summary of Hester Biosciences Ltd, including revenue, profit, loss and more.
Indices Featuring Hester Biosciences Ltd Stock
Check stock indices that include Hester Biosciences Ltd.
Hester Biosciences Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Hester Biosciences Ltd.
Hester Biosciences Ltd Earnings Results
Hester Biosciences Ltd’s net profit fell -73.94% since last year same period to ₹1.29Cr in the Q4 2024-2025. On a quarterly growth basis, Hester Biosciences Ltd has generated -88.94% fall in its net profits since last 3-months.
Read More about Earnings ResultsHester Biosciences Ltd Dividends May,2024
In the quarter ending March 2024, Hester Biosciences Ltd has declared dividend of ₹6 - translating a dividend yield of 0.78%.
Read More about Dividends
Hester Biosciences Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Hester Biosciences Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.73% | 0.00 | |
| Foreign Institutions | 0.87% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 45.38% | 0.00 | |
| Others | 0.02% | 0.00 |
Hester Biosciences Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Hester Biosciences Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,520.01 | 7.89% | 0.00 | NA | NA | |
| NA | 0.00 | -11.37% | 0.77 | NA | NA | |
| NA | 23,341.25 | 40.67% | 0.00 | NA | NA | |
| NA | 34.33 | 13.59% | 0.54 | NA | NA | |
| BUY | 5,752.91 | 16.58% | 0.50 | NA | NA |
Hester Biosciences Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Hester Biosciences Ltd.
Hester Biosciences Reports Significant Profit Decline - 09 May, 2025
Hester Biosciences' consolidated net profit fell 73.94% to Rs 1.29 crore in Q4 FY25, despite a 3.37% increase in net sales to Rs 81.93 crore. The company aims for growth through product development and international expansion.
Insights on Hester Biosciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 72.0 Cr → 76.29 Cr (in ₹), with an average increase of 5.6% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.59% to 0.87% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.4% return, outperforming this stock by 148.5%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.0% return, outperforming this stock by 43.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.73% of holdings in Mar 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 45.65% to 45.38% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 6 months, HESTERBIO stock has moved down by -31.3%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 11.66 Cr → 1.29 Cr (in ₹), with an average decrease of 88.9% per quarter
About Hester Biosciences Ltd
Revenue: ₹81.93Cr as on March 2025 (Q4 FY25)
Net Profit: ₹1.54Cr as on March 2025 (Q4 FY25)
Listing date: 13 Mar, 2015
| Organisation | Hester Biosciences Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Mutual Funds that own Hester Biosciences Ltd
Check out the Mutual Funds with significant holdings in Hester Biosciences Ltd.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Bandhan BSE Healthcare Index Fund Direct Growth | 0.05% |
FAQs
What is Hester Biosciences Ltd share price today?
Hester Biosciences Ltd share price today stands at ₹1798, Open: ₹1808, Previous Close: ₹1786.8, High: ₹1808, Low: ₹1762.1, 52 Week High: ₹3379, 52 Week Low: ₹1242.95.
What is today's traded volume of Hester Biosciences Ltd?
Today's traded volume of Hester Biosciences Ltd is 2,290.00. Which means that 2,290.00 shares of Hester Biosciences Ltd were bought and sold on the stock market during today's trading session.
What is Hester Biosciences Ltd's market cap today?
Today's market capitalisation of Hester Biosciences Ltd is ₹1,520.01 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Hester Biosciences Ltd?
Hester Biosciences Ltd’s 52 week high is ₹3379 and 52 week low is ₹1242.95. The current share price of Hester Biosciences Ltd is ₹1798, which is -46.79% down from its 52 week high and 44.66% up from its 52 week low.